Side-by-side comparison of AI visibility scores, market position, and capabilities
DTC mattress pioneer that launched the bed-in-a-box category with 100-night free returns; taken private after IPO competing with Purple and Saatva in the now-crowded online mattress market.
Casper is a direct-to-consumer sleep products company that pioneered the "bed-in-a-box" category — shipping compressed foam mattresses in compact boxes directly to consumers' homes, disrupting the traditional mattress retail model where consumers visited showrooms to buy from a limited selection at high markups. Founded in 2014 in New York by Philip Krim, Neil Parikh, T. Luke Sherwin, Jeff Chapin, and Gabriel Flatow, Casper went public in 2020 (NYSE: CSPR) but was taken private again in 2022 by Durational Capital Management after the stock underperformed.\n\nCasper's product line includes multiple mattress tiers (The Casper, Wave Hybrid, Nova Hybrid) across different price points, pillows, sheets, duvets, a dog mattress, and sleep accessories. The 100-night risk-free trial (free returns if unsatisfied) was a key innovation that reduced the risk of buying a mattress online without trying it — addressing the primary consumer objection to mattress e-commerce. Casper expanded into retail with showroom stores and retail partnerships (Target, retail stores) to let consumers experience products before buying online.\n\nIn 2025, Casper operates in the direct-to-consumer mattress market alongside Purple (NASDAQ: PRPL), Saatva, Nectar, and dozens of other online mattress brands that emerged after Casper proved the model in 2014-2016. The DTC mattress category became intensely competitive as the bed-in-a-box model was quickly replicated, compressing margins and raising customer acquisition costs. Private ownership under Durational Capital provides Casper with the ability to focus on sustainable unit economics without public market quarterly pressure. The 2025 strategy focuses on maintaining brand premium through product quality differentiation, growing the Sleep Shop retail presence, and building customer loyalty through the sleep ecosystem (mattress + accessories) rather than one-time mattress purchases.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.